Analysts: Keryx Biopharmaceuticals Inc (KERX.PH)

KERX.PH on Philadelphia Stock Exchange

15.21USD
10 Jul 2014
Price Change (% chg)

$-0.07 (-0.46%)
Prev Close
$15.28
Open
$14.73
Day's High
$15.24
Day's Low
$14.73
Volume
8,653
Avg. Vol
--
52-wk High
--
52-wk Low
--

Search Stocks

Consensus Recommendations

Consensus Recommendation Next Earnings (approx.) Company Fiscal Year
End Month
Last Updated
Outperform -0.25 December 11 Jul 2014

Analyst Recommendations and Revisions

1-5 Linear Scale Current 1 Month
Ago
2 Month
Ago
3 Month
Ago
(1) BUY 4 4 4 4
(2) OUTPERFORM 7 7 7 7
(3) HOLD 0 0 0 0
(4) UNDERPERFORM 0 0 0 0
(5) SELL 0 0 0 0
No Opinion 0 0 0 0
Mean Rating 1.64 1.64 1.64 1.64

Consensus Estimates Analysis

Sales and Profit Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
  # of Estimates Mean High Low 1 Year
Ago
SALES (in millions)
Quarter Ending Sep-14 11 4.88 35.40 0.00 10.75
Quarter Ending Dec-14 11 19.00 48.90 3.80 39.13
Year Ending Dec-14 10 28.05 58.23 15.00 48.79
Year Ending Dec-15 10 141.22 263.00 36.90 116.42
Earnings (per share)
Quarter Ending Sep-14 10 -0.25 -0.11 -0.34 0.04
Quarter Ending Dec-14 10 -0.13 0.26 -0.28 0.17
Year Ending Dec-14 10 -0.79 -0.41 -1.05 0.02
Year Ending Dec-15 10 0.20 2.28 -1.05 0.66

Historical Surprises

Sales and Profit Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
Estimates vs Actual Estimate Actual Difference Surprise %
SALES (in millions)
Quarter Ending Mar-14 9.91 10.00 0.09 0.89
Quarter Ending Dec-13 2.22 0.00 2.22 100.00
Quarter Ending Sep-13 2.22 0.00 2.22 100.00
Quarter Ending Jun-13 0.00 0.00 0.00 0.00
Quarter Ending Mar-13 5.83 7.00 1.17 20.00

Consensus Estimates Trend

Sales and Profit Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
  Current 1 Week
Ago
1 Month
Ago
2 Month
Ago
1 Year
Ago
SALES (in millions)
Quarter Ending Sep-14 4.88 4.88 4.88 5.20 10.75
Quarter Ending Dec-14 19.00 19.00 19.00 19.46 39.13
Year Ending Dec-14 28.05 28.05 28.05 30.45 48.79
Year Ending Dec-15 141.22 141.22 141.22 141.22 116.42

Estimates Revisions Summary

  Last Week Last 4 Weeks
Number Of Revisions: Up Down Up Down
Revenue
Quarter Ending Sep-14 0 0 0 0
Quarter Ending Dec-14 0 0 0 0
Year Ending Dec-14 0 0 0 0
Year Ending Dec-15 0 0 0 0
Earnings

Analyst Research Reports

Report Title Price
Provider: Thomson Reuters Stock Report
$25.00
Provider: New Constructs, LLC
$25.00
Provider: MacroRisk Analytics/EconomicInvestor
$25.00
Provider: ValuEngine, Inc.
$25.00
Provider: Wright Reports
$75.00

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

Search Stocks